AtonRa Partners Has $359,000 Stock Holdings in Neogen Co. (NASDAQ:NEOG)

AtonRa Partners trimmed its position in Neogen Co. (NASDAQ:NEOG) by 14.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,853 shares of the company’s stock after selling 3,113 shares during the quarter. AtonRa Partners’ holdings in Neogen were worth $359,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Allspring Global Investments Holdings LLC lifted its position in shares of Neogen by 416.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,033 shares of the company’s stock worth $56,000 after purchasing an additional 2,446 shares during the last quarter. C M Bidwell & Associates Ltd. acquired a new position in shares of Neogen during the third quarter worth approximately $151,000. Fifth Third Bancorp boosted its position in shares of Neogen by 10.7% in the third quarter. Fifth Third Bancorp now owns 9,967 shares of the company’s stock valued at $185,000 after acquiring an additional 966 shares during the period. Savant Capital LLC grew its stake in shares of Neogen by 9.4% in the third quarter. Savant Capital LLC now owns 10,320 shares of the company’s stock worth $191,000 after acquiring an additional 889 shares during the last quarter. Finally, Fox Run Management L.L.C. bought a new position in Neogen during the third quarter worth $201,000. Institutional investors and hedge funds own 96.73% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Piper Sandler reduced their price target on shares of Neogen from $19.00 to $17.00 and set a “neutral” rating for the company in a report on Monday, April 15th.

Neogen Stock Performance

NEOG traded up $0.28 on Monday, hitting $12.42. 1,911,738 shares of the stock traded hands, compared to its average volume of 2,138,015. The business has a fifty day moving average price of $14.81 and a two-hundred day moving average price of $16.32. The company has a current ratio of 3.82, a quick ratio of 2.66 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $2.69 billion, a PE ratio of 1,243.24 and a beta of 1.13. Neogen Co. has a 52 week low of $11.46 and a 52 week high of $24.09.

Neogen (NASDAQ:NEOG) last announced its quarterly earnings data on Tuesday, April 9th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.02). The firm had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. Neogen had a return on equity of 3.35% and a net margin of 0.17%. Neogen’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period in the previous year, the business posted $0.12 EPS. On average, research analysts predict that Neogen Co. will post 0.5 EPS for the current fiscal year.

Insider Buying and Selling at Neogen

In other Neogen news, CFO David H. Naemura bought 12,500 shares of the firm’s stock in a transaction dated Wednesday, April 10th. The shares were acquired at an average cost of $12.51 per share, for a total transaction of $156,375.00. Following the transaction, the chief financial officer now owns 30,040 shares in the company, valued at $375,800.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO John Edward Adent purchased 23,000 shares of the stock in a transaction on Wednesday, April 10th. The shares were purchased at an average cost of $12.36 per share, for a total transaction of $284,280.00. Following the completion of the transaction, the chief executive officer now directly owns 152,389 shares of the company’s stock, valued at approximately $1,883,528.04. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO David H. Naemura acquired 12,500 shares of the business’s stock in a transaction on Wednesday, April 10th. The shares were bought at an average cost of $12.51 per share, with a total value of $156,375.00. Following the completion of the acquisition, the chief financial officer now owns 30,040 shares of the company’s stock, valued at approximately $375,800.40. The disclosure for this purchase can be found here. Insiders have acquired 53,000 shares of company stock valued at $662,205 in the last 90 days. 0.71% of the stock is currently owned by company insiders.

Neogen Profile

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.